|
 |
Execute performed a detailed analysis of the technical and commercial operations of Proteom Limited, a year 4 structure-based design company.
Based upon this analysis, Avlar BioVentures were able to set the draw-down of £1,500,000 of further investment into the company against the achievement of relevant business milestones. |
| |